Free Trial

ImmunityBio (IBRX) SEC Filings & 10K Form

ImmunityBio logo
$3.36 +0.58 (+20.86%)
Closing price 03/27/2025 04:00 PM Eastern
Extended Trading
$3.38 +0.02 (+0.45%)
As of 03/27/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ImmunityBio SEC Filings

DateFilerForm TypeView
03/19/2025
7:14 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
6:42 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
6:47 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
8:11 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
LAUER REGAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:11 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Simon Barry J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:11 PM
Adcock Richard (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:11 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Sachs David C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
8:11 PM
CALIFORNIA CAPITAL EQUITY, LLC (Reporting)
Cambridge Equities, LP (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
MP 13 Ventures, LLC (Reporting)
Nant Capital, LLC (Reporting)
SOON-SHIONG PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:16 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
7:16 PM
Adcock Richard (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
7:16 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Sachs David C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
7:16 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
LAUER REGAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
7:17 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
SOON-SHIONG PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
7:47 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Simon Barry J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
3:54 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Sachs David C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
3:54 PM
Adcock Richard (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
6:36 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
LAUER REGAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
8:20 PM
CALIFORNIA CAPITAL EQUITY, LLC (Reporting)
Cambridge Equities, LP (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
MP 13 Ventures, LLC (Reporting)
Nant Capital, LLC (Reporting)
SOON-SHIONG PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
5:45 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 424B5
12/11/2024
6:46 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
4:28 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
4:13 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 424B5
11/19/2024
7:01 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:03 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2024
8:48 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
3:51 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/13/2024
5:49 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
MAXWELL LINDA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:49 PM
BLASZYK MICHAEL D (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:49 PM
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Selecky Christobel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:49 PM
Cohen Cheryl (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:49 PM
Clark Wesley (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:50 PM
Brennan John Owen (Reporting)
ImmunityBio, Inc. (Issuer)
ImmunityBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:36 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
4:00 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2024
11:15 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form EFFECT
04/29/2024
3:18 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form DEF 14A
04/29/2024
3:20 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form DEFA14A
04/23/2024
5:17 AM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
4:24 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form S-3ASR
03/28/2024
8:14 PM
ImmunityBio, Inc. (Filer)
ImmunityBio (Filer)
Form S-3
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:IBRX) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners